Diagnostic Scan – Ga68

By | October 4th, 2017|Treatment News|

The Gallium 68 scan, used with functional PET imaging, is a nuclear medicine scan that relies on the over-expression of somatostatin receptors to visualize tumours. NETs typically express several somatostatin […]

Somatuline (lanreotide) Access in Manitoba & Alberta

By | October 2nd, 2017|Treatment News|

As we advised previously, in July of this year the Manitoba government issued a bulletin http://www.gov.mb.ca/health/mdbif/…/bulletins/bulletin93.pdf that indicated a change in the listing for Somatuline […]

Caprelsa (vandetanib) for Medullary Thyroid Neuroendocrine Cancer

By | October 2nd, 2017|Treatment News|

Caprelsa is indicated for the treatment of symptomatic or progressive medullary thyroid cancer (MTC) in adult patients with unresectable locally advanced or metastatic disease.   An application for this […]

Afinitor (everolimus) for Neuroendocrine tumours of Gastrointestinal or Lung origin

By | October 2nd, 2017|Treatment News|

Afinitor is currently paid for by provincial drug plans for patients with well-or moderately differentiated neuroendocrine tumours of pancreatic origin (pNET), in patients with unresectable, locally advanced or […]

Dr. Suzanne Richter

By | April 4th, 2017|News|

It is with profound sadness that we share the news of the passing of Dr. Suzanne Richter, Medical Oncologist on the NET team at London Health Sciences Centre.  […]

CCO to provide Ga68 Scan to Ontario patients

By | March 28th, 2017|Clinical Trial, Education, Treatment News|

CCO to provide Ga-Octreotate to Ontario patients free of charge in Sherbrooke

A message from Helena Senta:
“At this time, CCO is proceeding with […]

Thank you

By | February 15th, 2017|News|

Thank you to all our donors and volunteers!

As we start anew into 2017, CNETS Canada would like to acknowledge and thank all our donors and volunteers for their […]

Campaign Shines Spotlight on Rare Cancer

By | November 9th, 2016|Awareness, News|

Media Release

Campaign Shines Spotlight on Rare Cancer on November 10th –World NET Cancer Day

Toronto, ON – November 10th, 2016 – Today is World NET Cancer Day. To raise […]


By | October 27th, 2016|Awareness, News|

Media Advisory

“LET’S TALK ABOUT NETs” Campaign Shines Spotlight on Rare Cancer

Toronto, ON – October 27, 2016 – Between 12,000 to 15,000 Canadians are estimated to have a rare […]

PRRT Clinical Trial Update – PMH Site

By | October 19th, 2016|Clinical Trial, Education, News, Treatment News|

On October 2, 2016, CNETS Canada held a Toronto Patient Education Day entitled PRRT Clinical Trial Update – PMH Site, with presentations by Dr. Rebecca Wong and Dr. Shereen […]